These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11101202)

  • 1. Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats.
    Minamino T; Kitakaze M; Papst PJ; Ueda Y; Sakata Y; Asanuma H; Ogai A; Kuzuya T; Terada N; Hori M
    Cardiovasc Drugs Ther; 2000 Oct; 14(5):533-42. PubMed ID: 11101202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis].
    Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Hori M; Kitakaze M
    J Cardiol; 2003 Jan; 41(1):43-4. PubMed ID: 12564115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase.
    Sanada S; Node K; Asanuma H; Ogita H; Takashima S; Minamino T; Asakura M; Liao Y; Ogai A; Kim J; Hori M; Kitakaze M
    J Am Coll Cardiol; 2002 Sep; 40(5):991-7. PubMed ID: 12225728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
    Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.
    Sanada S; Node K; Minamino T; Takashima S; Ogai A; Asanuma H; Ogita H; Liao Y; Asakura M; Kim J; Hori M; Kitakaze M
    Hypertension; 2003 Apr; 41(4):963-7. PubMed ID: 12629037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
    Takemoto M; Egashira K; Tomita H; Usui M; Okamoto H; Kitabatake A; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1997 Dec; 30(6):1621-7. PubMed ID: 9403592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
    Takemoto M; Egashira K; Usui M; Numaguchi K; Tomita H; Tsutsui H; Shimokawa H; Sueishi K; Takeshita A
    J Clin Invest; 1997 Jan; 99(2):278-87. PubMed ID: 9005996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ET(A) receptor antagonist ameliorates nephrosclerosis and left ventricular hypertrophy induced in rat by prolonged inhibition of nitric oxide synthesis.
    Nakamura T; Kurashina T; Saito Y; Sumino H; Akuzawa N; Aizawa H; Sakamoto H; Ono Z; Nagai R
    Hypertens Res; 1998 Dec; 21(4):251-7. PubMed ID: 9877518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression by ACE inhibition of arteriosclerotic changes induced by chronic blockade of NO synthesis in rats.
    Katoh M; Egashira K; Kataoka C; Usui M; Koyanagi M; Kitamoto S; Ohmachi Y; Takeshita A; Narita H
    Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2306-12. PubMed ID: 11299235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
    Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H
    Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term inhibition of nitric oxide synthesis increases arterial thrombogenecity in rat carotid artery.
    Kubo-Inoue M; Egashira K; Usui M; Takemoto M; Ohtani K; Katoh M; Shimokawa H; Takeshita A
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1478-84. PubMed ID: 11893585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of imidapril and candesartan cilexetil on plasminogen activator inhibitor-1 expression induced by prolonged inhibition of nitric oxide synthesis in rat hearts.
    Katoh M; Egashira K; Mitsui T; Takeshita A; Narita H
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):932-6. PubMed ID: 10836729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats.
    Kataoka C; Egashira K; Inoue S; Takemoto M; Ni W; Koyanagi M; Kitamoto S; Usui M; Kaibuchi K; Shimokawa H; Takeshita A
    Hypertension; 2002 Feb; 39(2):245-50. PubMed ID: 11847192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis.
    Akuzawa N; Nakamura T; Kurashina T; Saito Y; Hoshino J; Sakamoto H; Sumino H; Ono Z; Nagai R
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):697-707. PubMed ID: 9657629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.
    Suda O; Tsutsui M; Morishita T; Tanimoto A; Horiuchi M; Tasaki H; Huang PL; Sasaguri Y; Yanagihara N; Nakashima Y
    Circulation; 2002 Sep; 106(13):1729-35. PubMed ID: 12270870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury.
    Chen R; Iwai M; Wu L; Suzuki J; Min LJ; Shiuchi T; Sugaya T; Liu HW; Cui TX; Horiuchi M
    Hypertension; 2003 Oct; 42(4):542-7. PubMed ID: 12963679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of pulse wave velocity precedes vascular structural changes of the aorta in rats treated with N(omega)-nitro-L-arginine methyl ester.
    Kameyama H; Takeda K; Kusaba T; Narumiya H; Tanda S; Kuwahara N; Yamada K; Tamagaki K; Okigaki M; Hatta T; Sasaki S
    Hypertens Res; 2005 May; 28(5):439-45. PubMed ID: 16156508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.